← Back to Search

Vascular Access Device

Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device for Cardiac Arrest (UP-FRONT Trial)

N/A
Waitlist Available
Led By Michael C Kurz, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 minutes
Awards & highlights

UP-FRONT Trial Summary

This trial will study whether a procedure using a REBOA device to block the aorta can help people who have had a heart attack and haven't regained circulation.

Eligible Conditions
  • Cardiac Arrest
  • Ventricular Fibrillation
  • Ventricular Tachycardia

UP-FRONT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to successful deployment of device
Secondary outcome measures
Return of spontaneous circulation (ROSC)

UP-FRONT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard Care Plus InterventionExperimental Treatment1 Intervention
Participants randomized to this arm will receive standard care for cardiac arrest, which consists of advanced cardiovascular life support (ACLS) plus the study intervention
Group II: Standard CareActive Control1 Intervention
Participants randomized to this arm will receive standard care for cardiac arrest, which consists of advanced cardiovascular life support (ACLS)

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,280,044 Total Patients Enrolled
3 Trials studying Cardiac Arrest
3,887 Patients Enrolled for Cardiac Arrest
Michael C Kurz, MDPrincipal InvestigatorProfessor and Vice-Chair for Research, Department of Emergency Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available to partake in this experiment?

"The information posted on clinicaltrials.gov reports that this medical trial is not enrolling patients at the moment, having been publicised since October 1st 2022 and last updated April 26th 2022. Although recruitment has halted for this study, a plethora of other trials are actively seeking participants."

Answered by AI

How can I register for this research project?

"In order to be eligible for the trial, individuals must possess a diagnosis of ventricular fibrillation and fall between 18 and 70 years old. Currently there are 40 spots available in this medical study."

Answered by AI

Is the eligibility for participation in this trial limited to younger individuals or are those aged 60 and above also able to join?

"This medical study requires all participants to be of legal age and below 70 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application (UP-FRONT)
Michael C. Kurz 2022. "Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application (UP-FRONT)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05236920.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top